MedTrace Logo

Examining the Effects of Antipsychotic Medications on Insulin Sensitivity

NCT00895921 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2020-08-11

Study results available
· View outcomes & findings →

Summary

This study will examine the effects of two different antipsychotic medications on control of blood sugar in people who are at risk of diabetes but mentally healthy.

Conditions

Interventions

DRUG

Olanzapine

Single intramuscular 10-mg dose

DRUG

Aripiprazole

Single intramuscular 9.75-mg dose

Sponsors & Collaborators

  • National Institute of Mental Health (NIMH)

    collaborator NIH

  • Veterans Medical Research Foundation

    lead OTHER

Principal Investigators

  • Jonathan M. Meyer, MD · UCSD and Veterans Affairs San Diego

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-12-31
Completion
2010-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00895921 on ClinicalTrials.gov